These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25840940)

  • 41. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases.
    Martin PL; Carter SL; Kernan NA; Sahdev I; Wall D; Pietryga D; Wagner JE; Kurtzberg J
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):184-94. PubMed ID: 16443516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving Quality and Potency Testing for Umbilical Cord Blood: A New Perspective.
    Rich IN
    Stem Cells Transl Med; 2015 Sep; 4(9):967-73. PubMed ID: 26160959
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Umbilical cord blood transplantation--how, when and for whom?
    Cohen Y; Nagler A
    Blood Rev; 2004 Sep; 18(3):167-79. PubMed ID: 15183901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advances in umbilical cord blood manipulation-from niche to bedside.
    Lund TC; Boitano AE; Delaney CS; Shpall EJ; Wagner JE
    Nat Rev Clin Oncol; 2015 Mar; 12(3):163-74. PubMed ID: 25511187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Umbilical cord blood transplantation: a new alternative option.
    Tse W; Laughlin MJ
    Hematology Am Soc Hematol Educ Program; 2005; ():377-83. PubMed ID: 16304407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
    Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cord blood banking and transplantation: advances and controversies.
    Yoder MC
    Curr Opin Pediatr; 2014 Apr; 26(2):163-8. PubMed ID: 24553632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ex vivo expansion of umbilical cord blood for transplantation.
    Tung SS; Parmar S; Robinson SN; De Lima M; Shpall EJ
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):245-57. PubMed ID: 20837337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ex vivo expansion of cord blood.
    Kelly SS; Sola CB; de Lima M; Shpall E
    Bone Marrow Transplant; 2009 Nov; 44(10):673-81. PubMed ID: 19802023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methods of ex vivo expansion of human cord blood cells: challenges, successes and clinical implications.
    Baron F; Ruggeri A; Nagler A
    Expert Rev Hematol; 2016 Mar; 9(3):297-314. PubMed ID: 26635058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors Influencing the Umbilical Cord Blood Stem Cell Industry: An Evolving Treatment Landscape.
    Dessels C; Alessandrini M; Pepper MS
    Stem Cells Transl Med; 2018 Sep; 7(9):643-650. PubMed ID: 29777574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cord blood immunology and stem cell transplantation.
    Bradley MB; Cairo MS
    Hum Immunol; 2005 May; 66(5):431-46. PubMed ID: 15935881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cord blood versus haploidentical stem cell transplantation for hematological malignancies.
    Kekre N; Antin JH
    Semin Hematol; 2016 Apr; 53(2):98-102. PubMed ID: 27000733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Umbilical cord blood: an alternative to the transplantation of bone marrow stem cells.
    Weber-Nordt RM; Schott E; Finke J; Henschler R; Schulz G; Mertelsmann R
    Cancer Treat Rev; 1996 Sep; 22(5):381-91. PubMed ID: 9118123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cord blood biology and transplantation.
    Cohen Y; Nagler A
    Isr Med Assoc J; 2004 Jan; 6(1):39-46. PubMed ID: 14740509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft.
    Wagner JE; Brunstein CG; Boitano AE; DeFor TE; McKenna D; Sumstad D; Blazar BR; Tolar J; Le C; Jones J; Cooke MP; Bleul CC
    Cell Stem Cell; 2016 Jan; 18(1):144-55. PubMed ID: 26669897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell doses.
    Terakura S; Azuma E; Murata M; Kumamoto T; Hirayama M; Atsuta Y; Kodera Y; Yazaki M; Naoe T; Kato K
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):822-30. PubMed ID: 17580260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions.
    Prasad VK; Kurtzberg J
    Br J Haematol; 2010 Feb; 148(3):356-72. PubMed ID: 19919654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hematopoietic stem cell transplantation for mucopolysaccharidoses and leukodystrophies.
    Sauer M; Grewal S; Peters C
    Klin Padiatr; 2004; 216(3):163-8. PubMed ID: 15175961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.